Theriva Biologics TOVX
NYSE TOVX
$0.19 0.00 (-1.48%)
As of: Oct 22, 2026 · 10:50 AM EDT

Theriva Biologics (TOVX) Net Margin (2010 - 2026)

Updated

Theriva Biologics (TOVX) recorded Net Margin of -681.33% in Q1 2026.

Analysis

Theriva Biologics (TOVX) Net Margin (2010 - 2026) Analysis & Trends

For FY2010, Theriva Biologics reported Net Margin of -65.46%.

  • The Q1 2026 figure is the highest quarterly Net Margin since Q3 2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Eli Lilly 1,167.56 Bn 1,136.14 Bn 19.71 Bn 30.88%
2 Johnson & Johnson 635.76 Bn 554.29 Bn 17.26 Bn 21.86%
3 AbbVie 503.27 Bn 476.38 Bn 12.70 Bn 21.27%
4 Merck 377.51 Bn 331.89 Bn 12.21 Bn -8.04%
5 Novartis Ag 304.07 Bn 268.06 Bn 11.24 Bn 22.65%
6 Astrazeneca 267.53 Bn 241.22 Bn 12.86 Bn 16.30%
7 Amgen 242.06 Bn 197.46 Bn 7.24 Bn 23.62%
8 Gilead Sciences 194.26 Bn 168.46 Bn 6.22 Bn -134.51%
9 Pfizer 172.62 Bn 119.27 Bn 10.94 Bn -1.65%
10 Theriva Biologics 8.89 Mn -37.46 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -681.33%
Sep 30, 2011 -374.21%
Jun 30, 2011 -472.49%
Dec 31, 2010 -1,258.29%
Sep 30, 2010 -252.79%
Jun 30, 2010 44.64%
API Access

Theriva Biologics Net Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-margin&ticker=TOVX&period=max&api_key=YOUR_API_KEY